View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, Feb. 15 (HealthDay News) -- Women who develop problematic hot flashes after breast cancer treatment, where hormone replacement therapy is contraindicated, see significant improvement in quality of life after receiving behavioral therapy, according to a study published online Feb. 15 in The Lancet Oncology.
Eleanor Mann, D.Phil., from King's College London, and colleagues randomly assigned 96 women who had developed hot flashes and night sweats (HFNS; at least 10 episodes per week) after breast cancer treatment to either usual care or usual care plus group cognitive behavioral therapy. Group therapy consisted of one 90-minute session per week for six weeks, offering education about HFNS and cognitive and behavioral strategies to manage the problem.
The researchers found that women who received cognitive behavioral therapy had significantly reduced HFNS problem ratings, with a reduction in average scores of 46 percent after nine weeks and 52 percent after 26 weeks. In contrast, women who received usual care had reductions of only 19 and 25 percent, respectively. There were no adverse events related to the therapy noted.
"Group cognitive behavioral therapy seems to be a safe and effective treatment for women who have problematic HFNS after breast cancer treatment, with additional benefits to mood, sleep, and quality of life," Mann and colleagues conclude.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top